Trial Profile
Vilazodone and CYP3A4 inhibition
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Vilazodone (Primary) ; Ketoconazole
- Indications Generalised anxiety disorder; Major depressive disorder; Sexual function disorders; Social phobia
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Forest Laboratories; PGxHealth
- 03 Dec 2015 New trial record